Op deze pagina vindt u het laatste nieuws uit de wereld van klinisch onderzoek! Voor het nieuwsoverzicht (nieuwsfeed) op deze pagina worden van een aantal organisaties, instanties, bedrijven en personen de RSS feeds gevolgd. De RSS feeds worden elke 5 – 10 minuten ververst en op deze pagina weergegeven. Voor een overzicht van alle nieuwsbronnen, klik hier.
Omdat de plug-in die ik voor deze pagina gebruik niet overweg kan met de RSS feeds van een aantal organisaties, instanties, bedrijven en personen heb ik een alternatieve pagina ingericht om de RSS feeds van deze organisaties, instanties, bedrijven en personen toch weer te kunnen geven. Klik hier om het alternatieve nieuwsoverzicht te raadplegen.
Meer nieuws en actualiteiten:
- Alternatief nieuwsoverzicht
- Archief Nieuwsbrief voor Goede Onderzoekspraktijken
- Uitgelicht & Gespot op internet
Nieuwsfeed
- FDA Roundup: July 26, 2024
- User Fee Lists
- Administrative Guidances
- C3TI Compass (Knowledge Repository)
- Foreign National Charged for Selling Counterfeit Cancer Drugs
- Upstate Pharmacist Sentenced for Unlawfully Compounding Radioactive Drugs
- Untitled Letters
- FDA committee proposes overhaul of perioperative lung cancer trials
- TESTING ==> The latest from Academia Archives - Undark Magazine for 07/26/2024
- Premier Manufacturing Products, LLC - 678912 - 07/02/2024
- Safe Opioid Disposal - Remove the Risk Outreach Toolkit
- Blood Guidances
- Sticking to the Plan: Undue Burden Created by Protocol Deviations
- Viking’s new dual GLP-1R/GIPR agonist expected to start Phase III trials soon
- Immunis to use MRI-based AI muscle analysis for sarcopenia trial
- Advancing Generic Drug Development: Translating Science to Approval 2024 - 09/24/2024
- Safely Soothing Teething Pain in Infants and Children
- Guidance for Industry for the Evaluation of Combination Vaccines for Preventable Diseases: Production, Testing and Clinical Studies
- Ggz-aanbieder BreinPoli krijgt ‘deksel op de neus’ van rechter
- Generic Drug Facilities, Sites and Organization Lists
- Proposed Approach to Regulation of Cellular and Tissue-Based Products
- Cue Biopharma downsizes to focus on autoimmune pipeline
- Guidance for Industry for the Submission of Chemistry, Manufacturing, and Controls Information for a Therapeutic Recombinant DNA-Derived Product or a Monoclonal Antibody Product for In Vivo Use
- We Are Hiring
- FDA Guidance Document Concerning Use of Pilot Manufacturing Facilities for the Development and Manufacture of Biological Products
- Clinical trial diversity is a balancing act of time, quality, and money
- Zorgaanbieders in Noord-Limburg verbeteren de palliatieve zorg met Palliakit
- FDA Talks Help Cybin Advance Two Psychedelic Drugs Toward Approval
- What's New Related to Drugs
- Compounding Risk Alerts
- The latest from Undark Magazine for 07/26/2024
- Concept paper on the revision of the guideline on dossier requirements for anticancer medicinal products for dogs and cats
- FDA alerts health care providers, compounders and patients of dosing errors associated with compounded injectable semaglutide products
- CDER Conversations
- EMA keurt medicijn tegen Alzheimer af
- Authors up past 60 retractions amid ongoing investigation
- Guidance Development and Regulatory Assessment of Generic Topical and Dermal Drug Products - 10/03/2024
- Accelerating Access to Critical Therapies for ALS Act – ACT for ALS
- Nieuwsbrief Health-RI Juli 2024
- Concept paper on the revision of the guideline on veterinary medicinal products controlling Varroa destructor parasitosis in bees
- The RW Daily: Why did a pediatric journal publish articles on the elderly? And researcher withdraws from council and dismissed as director of school.
- Calliditas’ Phase IIb trial of PBC treatment meets primary endpoint
- Highlands Oncology and Paradigm report 45% rise in Northwest Arkansas trials
- Nieuwe bestuurder voor Zorggroep Ter Weel
- Template for notified body confirmation letter of the status of a formal application, written agreement, and appropriate surveillance in the framework of Reg EU 2024/1860
- Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 22-25 July 2024
- EMA advises about risks of using weight loss medicine Mysimba with opioids
- DIA's Impact on the Clinical Research Industry
- Early-Phase Trial Indicates Potential of Fecal Microbiota Transplant in Overcoming Resistance to Immune Checkpoint Inhibitors
- Forget about AI, Here Comes PowerPoint